Read Trending Stories
- » Ultimate Market Recap: Talbots Tanks, Facebook Fiasco Continues
- » Are Facebook Losses Bigger Than Initially Thought?
- » Consumer Business Recap: Toyota Needs Emerging Markets, Wal-Mart's Express Update
- » Consumer Biz Recap: Talbots CRASHES HARD, Time Warner Eyes Sports Website
- » Your Cheat Sheet to Apple's Week of Stock Moving News
Today's Trending Stocks
Click a Company to Research Now:
- Bank of America (BAC)
- Apple . (AAPL)
- Facebook (FB)
- AT&T (T)
- Nokia (NOK)
- Delcath Systems (DCTH)
- Mentor Graphics Corp (MENT)
- Complete Genomics (GNOM)
Monsanto Company (NYSE:MON) announced today that it has successfully completed its third year of collaborative research with Evogene Ltd. Using its computational genetics technology, Evogene has discovered genes while predicting and providing validation in the model’s chosen plants for Monsanto.
In this five-year study, the two companies are attempting to discover genes that will enhance crop yields in corn, soybean, cotton and canola for farmers. For the project, Evogene is looking at key plant genes for yield, environmental stress, and fertilizer utilization for Monsanto to evaluate and develop commercially. During the next two years, Evogene will look at additional performance data for the selected genes and also consider additional products for farmers to grow through Monsanto’s help.
Monsanto’s stock (NYSE:MON) is down 1.96% to $64.57 in the market crash. Shares are down 7.31% year to date. The stock has traded in a 52-week range between $47.07 and $77.09.
Competitors to Watch: SSyngenta AG (NYSE:SYT), The Scotts Miracle-Gro Co. (NYSE:SMG), The Dow Chemical Company (NYSE:DOW), FMC Corporation (NYSE:FMC), The Mosaic Company (NYSE:MOS), American Vanguard Corp. (NYSE:AVD), Potash (NYSE:POT), CF Industries Hldgs., Inc. (NYSE:CF) and Origin Agritech Ltd. (NASDAQ:SEED).
Get Your FREE Special Report: 4 Things You Must Know About the US Economy Now!
Do You Want More Profits? Wall St. Cheat Sheet Premium newsletter subscribers have been crushing the markets with winning stock picks.
Click here now for your FREE trial to our acclaimed flagship newsletter:
